Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AVXL - Anavex and Cyclo are extending the Alzheimer's-driven rally

AVXL - Anavex and Cyclo are extending the Alzheimer's-driven rally

Anavex Life Sciences Corp.
Anavex Life Sciences (AVXL) and Cyclo Therapeutics (CYTH) are continuing the momentum following the announcement by Cassava Sciences (NASDAQ:SAVA) on Tuesday that its lead asset simufilam generated positive interim data in an open-label study.Though Cassava has reversed the gains with a loss of ~16.7% today, Anavex has added ~62.6% following the ~37.9 gain yesterday.Cyclo is the latest entrant to the rally, spiking ~52.0% after three successive double-digit percentage gains in previous trading sessions.According to the company’s latest quarterly filing, Cyclo has struck an agreement with a Contract Research Organization for a clinical trial to evaluate the safety and efficacy of Trappsol® Cyclo™ for the treatment of Alzheimer’s disease.Expecting a submission in early 2021, the company has also prepared a synopsis for an early stage protocol using the experimental therapy intravenously in Alzheimer’s Disease.

For further details see:

Anavex and Cyclo are extending the Alzheimer’s-driven rally
Stock Information
Company Name: Anavex Life Sciences Corp.
Stock Symbol: AVXL
Market: NASDAQ
Website: anavex.com
Menu
AVXL AVXL Quote AVXL Short AVXL News AVXL Articles AVXL Message Board
Get AVXL Alerts

News, Short Squeeze, Breakout and More Instantly...